ConductScience.org, home
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
API referenceFor AI assistants

Trial · NCT04242498

Participant flow42

How many started, completed or left each group, period by period.

1 to 20 of 42

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Initial Treatment Period: Week 0-16STARTEDPlacebo74
Initial Treatment Period: Week 0-16STARTEDBKZ Dosing Regimen 1144
Initial Treatment Period: Week 0-16STARTEDBKZ Dosing Regimen 2291
Initial Treatment Period: Week 0-16STARTEDPlacebo/BKZ Dosing Regimen 20
Initial Treatment Period: Week 0-16STARTEDBKZ Dosing Regimen 1/BKZ Dosing Regimen 10
Initial Treatment Period: Week 0-16STARTEDBKZ Dosing Regimen 2/BKZ Dosing Regimen 10
Initial Treatment Period: Week 0-16STARTEDBKZ Dosing Regimen 2/BKZ Dosing Regimen 20
Initial Treatment Period: Week 0-16COMPLETEDPlacebo69
Initial Treatment Period: Week 0-16COMPLETEDBKZ Dosing Regimen 1133
Initial Treatment Period: Week 0-16COMPLETEDBKZ Dosing Regimen 2262
Initial Treatment Period: Week 0-16COMPLETEDPlacebo/BKZ Dosing Regimen 20
Initial Treatment Period: Week 0-16COMPLETEDBKZ Dosing Regimen 1/BKZ Dosing Regimen 10
Initial Treatment Period: Week 0-16COMPLETEDBKZ Dosing Regimen 2/BKZ Dosing Regimen 10
Initial Treatment Period: Week 0-16COMPLETEDBKZ Dosing Regimen 2/BKZ Dosing Regimen 20
Initial Treatment Period: Week 0-16NOT COMPLETEDPlacebo5
Initial Treatment Period: Week 0-16NOT COMPLETEDBKZ Dosing Regimen 111
Initial Treatment Period: Week 0-16NOT COMPLETEDBKZ Dosing Regimen 229
Initial Treatment Period: Week 0-16NOT COMPLETEDPlacebo/BKZ Dosing Regimen 20
Initial Treatment Period: Week 0-16NOT COMPLETEDBKZ Dosing Regimen 1/BKZ Dosing Regimen 10
Initial Treatment Period: Week 0-16NOT COMPLETEDBKZ Dosing Regimen 2/BKZ Dosing Regimen 10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04242498/flow

API referenceFor AI assistants